Comparison of efficacy and safety of entecavir and switching from entecavir to tenofovir alafenamide fumarate in chronic hepatitis B: Long-term effects from a prospective study.
Satoru HagiwaraNaoshi NishidaKazuomi UeshimaAkihiro YoshidaYasunori MinamiMasatoshi KudoPublished in: Hepatology research : the official journal of the Japan Society of Hepatology (2021)
When compared with patients who received continuous ETV, those who were introduced to TAF after ETV showed similar effects in terms of the decrease in HBsAg level and safety.